- Home
- ABTS vs CARM Comparison
ABTS vs CARM Comparison
Compare ABTS & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- CARM
- Stock Information
- Founded
- ABTS 2010
- CARM 2016
- Country
- ABTS Hong Kong
- CARM United States
- Employees
- ABTS N/A
- CARM N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- ABTS Technology
- CARM Health Care
- Exchange
- ABTS Nasdaq
- CARM Nasdaq
- Market Cap
- ABTS 16.0M
- CARM 17.4M
- IPO Year
- ABTS N/A
- CARM N/A
- Fundamental
- Price
- ABTS $0.46
- CARM $0.42
- Analyst Decision
- ABTS
- CARM Hold
- Analyst Count
- ABTS 0
- CARM 5
- Target Price
- ABTS N/A
- CARM $4.57
- AVG Volume (30 Days)
- ABTS 89.5K
- CARM 361.4K
- Earning Date
- ABTS 12-31-2024
- CARM 11-07-2024
- Dividend Yield
- ABTS N/A
- CARM N/A
- EPS Growth
- ABTS N/A
- CARM N/A
- EPS
- ABTS N/A
- CARM N/A
- Revenue
- ABTS $5,343,888.00
- CARM $20,268,000.00
- Revenue This Year
- ABTS N/A
- CARM $46.34
- Revenue Next Year
- ABTS N/A
- CARM N/A
- P/E Ratio
- ABTS N/A
- CARM N/A
- Revenue Growth
- ABTS 3970.67
- CARM 41.13
- 52 Week Low
- ABTS $0.38
- CARM $0.38
- 52 Week High
- ABTS $1.60
- CARM $3.16
- Technical
- Relative Strength Index (RSI)
- ABTS 40.47
- CARM 18.28
- Support Level
- ABTS $0.41
- CARM $0.38
- Resistance Level
- ABTS $0.58
- CARM $0.50
- Average True Range (ATR)
- ABTS 0.07
- CARM 0.06
- MACD
- ABTS -0.02
- CARM -0.02
- Stochastic Oscillator
- ABTS 14.52
- CARM 7.31
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.